ASPC 2018 Congress on CVD Prevention

 

ASPC 2018 Congress on CVD Prevention
Avatar

Differentiating Antiplatelet Agents

By ASPC 2018 Congress on CVD Prevention FEATURING Peter Toth
By ASPC 2018 Congress on CVD Prevention FEATURING Peter Toth
626 views
August 10, 2018
Comments 0
Login to view comments. Click here to Login

Featured Video

04:47
Novartis Cardiology

Examining MOA, Safety, and Efficacy Data for a Non-Statin Lipid-Lowe…

Featured Video

48:22
Lilly Diabetes

A Journey Through Clinical Efficacy and Safety Data Comparing Two T2…

Feat. B. Hirsch
SESSION 3 - Cardiometabolic
28:08

Role of SGLT2/GLP1 Agents in a Preventive Cardiologist’s Practice, a…

ASPC 2018 Congress on CVD Prevention

M. Kosiborod

978 views
24:44

Comprehensive Approach to Lowering CVD Risk in Diabetics

ASPC 2018 Congress on CVD Prevention

Y. Handelsman

779 views
23:46

Differentiating Antiplatelet Agents

ASPC 2018 Congress on CVD Prevention

P. Toth

626 views
18:12

SESSION 3 - Cardiometabolic Discussion

ASPC 2018 Congress on CVD Prevention

23 views